The ModiFY Study

  • 15 replies
  • 25 subscribers
  • 3013 views

This trial is currently underway and will be opening again for more candidates in some locations in due course.  I've been provided the info as I tick the boxes.  It will open at my unit, Edinburgh Western.  

The purpose of the study is to find out if new treatment Modi-1 can be used safely for breast, H&N, ovarian or renal cancer and benefit these types of cancer.  Modi-1 is designed to help your immune system attack and destroy cancer cells.

Brief Summary: "The main objectives of this study are to assess the safety, tolerability, immunological activity, and preliminary efficacy of the Modi-1/Modi-1v vaccine, both as monotherapy and in combination with a checkpoint inhibitor (CPI) such as pembrolizumab or nivolumab (where these are standard of care in a non-neoadjuvant setting), in patients with advanced triple negative breast cancer (TNBC), advanced/unresectable human papillomavirus-negative squamous cell carcinoma of the head and neck (SCCHN), high grade serous ovarian carcinoma (HGSOC), or renal cell carcinoma (RCC)."

I'm just sharing as a heads-up, to meet others considering it, or on it.  I did a search of the forum and surprisingly didn't find anything.